Fig. 5From: Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational studyChange in supervision time (propensity score-adjusted). *p < 0.05; **p < 0.01; ****p < 0.0001 for difference between study type at that time point; p = 0.0001 for overall difference between study type; p = 0.0254 for study type × visit interaction. EU EuropeanBack to article page